The S&P 500 closed Tuesday at 7,673.52, down 0.58% (45.08 points), as a sharp decline in healthcare shares offset gains in energy and select technology names. The Dow Jones Industrial Average fell more than twice as much, dropping 1.18%, while the Nasdaq Composite slipped just 0.32% to 26,421.41. The Russell 2000 also retreated 0.52% to 2,960.20.
The divergence between the major indices underscores the sector-specific nature of Tuesday's moves. While the headline decline was modest, the underlying crosscurrents were anything but calm. The S&P 500 remains up 12.1% for 2026, but the day's action revealed a market grappling with rising oil prices, disappointing clinical trial results, and shifting expectations for interest rates.
Oil's Ascent and Inflation Jitters
Brent crude climbed to as high as $99.46 a barrel before settling at $97.92, up 0.9%, as geopolitical tensions in the Middle East raised supply concerns. The approach to the psychologically important $100 level reignited inflation fears, complicating the Federal Reserve's policy outlook. Higher energy costs threaten profit margins for transportation, consumer, and industrial companies, while also putting upward pressure on consumer prices.
However, the energy sector itself benefited, rising approximately 1.1%. This gain, coupled with strength in some semiconductor names, helped cushion the broader index from the healthcare rout.
Healthcare Rout: A Deeper Break
The most significant sector move came from healthcare, which fell roughly 2.5%. The catalyst was Novartis's announcement that its pelacarsen cardiovascular study failed to meet its primary endpoint. The company's U.S.-listed shares plunged nearly 14%. The negative read-through hit competitors, with Amgen dropping 10.08% and Stryker losing 8.81%.
This healthcare selloff was the primary driver of the Dow's outsized decline. Amgen's high share price—closing at $393.17—made it a heavyweight in the price-weighted Dow, while its smaller market-cap weight limited its impact on the S&P 500.
Index Construction Explains the Gap
The S&P 500 is weighted by float-adjusted market value, giving the largest companies the most influence. In contrast, the Dow is price-weighted, meaning a stock with a high price has a disproportionate effect, regardless of its total market value. This structural difference explains why the Dow fell so much more than the S&P 500 on Tuesday.
Technology also played a role in mitigating the S&P's decline. While losses in Nvidia, Apple, and Microsoft weighed on the index, gains in Broadcom, AMD, Intel, and Tesla provided offsets. This tug-of-war between sectors was invisible in the S&P's modest headline drop.
Treasury Yields Add to the Pressure
The Treasury market offered no haven. The two-year yield rose to 4.39% from 4.37% on Friday, and the 10-year yield climbed to 4.80% from 4.78%. These small increases are significant when oil is already stoking inflation concerns. Higher discount rates reduce the present value of future earnings, with growth stocks typically the most sensitive.
The Nasdaq's relatively smaller decline suggests the market has not yet experienced a full valuation shock. But if yields continue to rise and technology stops offsetting weakness in other sectors, the S&P could lose its cushion quickly.
Earnings Estimates Remain Supportive
Despite the headwinds, corporate earnings forecasts offer a counterargument. FactSet reported that analysts raised the S&P 500's bottom-up third-quarter earnings estimate by 1.2% from June 30 through August 31. The calendar-2026 estimate rose 6.1% to $361.38. Energy's third-quarter estimate increased 11.8%, reflecting the transfer of higher commodity prices to producer profits.
At Tuesday's close, the S&P 500 traded at approximately 21.2 times the calendar-2026 earnings estimate. This valuation suggests that much of the improvement in earnings is already priced in, leaving little room for disappointment if yields rise further or margins come under pressure.
What to Watch Next
The market's next test comes with the August Producer Price Index on Thursday, September 10, followed by the Consumer Price Index on Friday. The Federal Open Market Committee meets September 15–16. A benign inflation report with stable or lower yields would support the view that the oil shock is manageable and sector-specific. Hotter data, higher yields, and weaker technology would signal a broader de-rating.
A fresh supply disruption pushing Brent decisively above $100 would create the hardest scenario: stronger energy earnings alongside weaker margins and tighter Fed constraints. For now, the S&P 500 absorbed an oil shock and a healthcare rout without a disorderly selloff, but the internal offsets that kept the decline modest may not survive the upcoming inflation data.
